SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-370954
Filing Date
2015-11-09
Accepted
2015-11-09 06:40:33
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d11409d10q.htm 10-Q 533480
2 EX-31.1 d11409dex311.htm EX-31.1 6078
3 EX-31.2 d11409dex312.htm EX-31.2 6126
4 EX-32.1 d11409dex321.htm EX-32.1 3420
11 GRAPHIC g11409tx_pg17.jpg GRAPHIC 176565
  Complete submission text file 0001193125-15-370954.txt   3006357

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT epzm-20150930.xml EX-101.INS 383655
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20150930.xsd EX-101.SCH 38422
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20150930_cal.xml EX-101.CAL 47600
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20150930_def.xml EX-101.DEF 101637
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20150930_lab.xml EX-101.LAB 305539
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20150930_pre.xml EX-101.PRE 204585
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 151213906
SIC: 2834 Pharmaceutical Preparations